Advertisement
Screener

ICOSAVAX, INC. Other Income and Expense

ICOSAVAX, INC. Other Income and Expense

ICOSAVAX, INC. reported Other Income and Expense of $3.23 million for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.

Discontinued › Income Statement › Other Income

us-gaap:NonoperatingIncomeExpense · last filed 2023-11-14

  • ICOSAVAX, INC. nonoperating income (expense) for the quarter ending 2023-09-30 was $3.23M, a 177.12% increase year-over-year.
  • ICOSAVAX, INC. nonoperating income (expense) for the quarter ending 2023-06-30 was $2.46M, a 396.57% increase year-over-year.
  • ICOSAVAX, INC. nonoperating income (expense) for the quarter ending 2023-03-31 was $1.96M, a 1534.17% increase year-over-year.
  • ICOSAVAX, INC. nonoperating income (expense) for the quarter ending 2022-12-31 was $1.52M, a 5134.48% increase year-over-year.
  • ICOSAVAX, INC. nonoperating income (expense) for fiscal 2022 was $3.30M.
  • ICOSAVAX, INC. nonoperating income (expense) for fiscal 2021 was -$1.11M.
  • ICOSAVAX, INC. nonoperating income (expense) for fiscal 2020 was -$144.00K.
Period endNonoperating Income (Expense) 3 monthNonoperating Income (Expense) 6 monthNonoperating Income (Expense) 9 monthNonoperating Income (Expense) 12 month
2023-09-30$3.23M
10-Q · filed 2023-11-14
$5.69M
derived: sum of 2 quarters · filed 2023-11-14
$7.65M
10-Q · filed 2023-11-14
$9.17M
derived: sum of 4 quarters · filed 2023-11-14
2023-06-30$2.46M
10-Q · filed 2023-08-14
$4.42M
10-Q · filed 2023-08-14
$5.94M
derived: sum of 3 quarters · filed 2023-08-14
$7.10M
derived: sum of 4 quarters · filed 2023-11-14
2023-03-31$1.96M
10-Q · filed 2023-05-10
$3.48M
derived: sum of 2 quarters · filed 2023-05-10
$4.65M
derived: sum of 3 quarters · filed 2023-11-14
$5.14M
derived: sum of 4 quarters · filed 2023-11-14
2022-12-31$1.52M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30
$2.69M
derived: sum of 2 quarters · filed 2023-11-14
$3.18M
derived: sum of 3 quarters · filed 2023-11-14
$3.30M
10-K · filed 2023-03-30
2022-09-30$1.17M
10-Q · filed 2023-11-14
$1.66M
derived: sum of 2 quarters · filed 2023-11-14
$1.78M
10-Q · filed 2023-11-14
$1.81M
derived: sum of 4 quarters · filed 2023-11-14
2022-06-30$495.00K
10-Q · filed 2023-08-14
$615.00K
10-Q · filed 2023-08-14
$644.00K
derived: sum of 3 quarters · filed 2023-08-14
$671.00K
derived: sum of 4 quarters · filed 2023-08-14
2022-03-31$120.00K
10-Q · filed 2023-05-10
$149.00K
derived: sum of 2 quarters · filed 2023-05-10
$176.00K
derived: sum of 3 quarters · filed 2023-05-10
$218.00K
derived: sum of 4 quarters · filed 2023-05-10
2021-12-31$29.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30
$56.00K
derived: sum of 2 quarters · filed 2023-03-30
$98.00K
derived: sum of 3 quarters · filed 2023-03-30
-$1.11M
10-K · filed 2023-03-30
2021-09-30$27.00K
10-Q · filed 2022-11-14
$69.00K
derived: sum of 2 quarters · filed 2022-11-14
-$1.14M
10-Q · filed 2022-11-14
-$1.23M
derived: sum of 4 quarters · filed 2022-11-14
2021-06-30$42.00K
10-Q · filed 2022-08-15
-$1.17M
10-Q · filed 2022-08-15
-$1.26M
derived: sum of 3 quarters · filed 2022-08-15
-$1.38M
derived: sum of 4 quarters · filed 2022-08-15
2021-03-31-$1.21M
10-Q · filed 2022-05-16
-$1.30M
derived: sum of 2 quarters · filed 2022-05-16
-$1.42M
derived: sum of 3 quarters · filed 2022-05-16
-$1.41M
derived: sum of 4 quarters · filed 2022-05-16
2020-12-31-$93.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30
-$214.00K
derived: sum of 2 quarters · filed 2022-03-30
-$205.00K
derived: sum of 3 quarters · filed 2022-03-30
-$144.00K
10-K · filed 2022-03-30
2020-09-30-$121.00K
10-Q · filed 2021-11-15
-$112.00K
derived: sum of 2 quarters · filed 2021-11-15
-$51.00K
10-Q · filed 2021-11-15
2020-06-30$9.00K
10-Q · filed 2021-09-13
$70.00K
10-Q · filed 2021-09-13